| Year |
Citation |
Score |
| 2024 |
Zhou C, Satpute V, Yip KL, Anderson LL, Hawkins N, Kearney J, Arnold JC. A high seizure burden increases several prostaglandin species in the hippocampus of a Scn1a mouse model of Dravet syndrome. Prostaglandins & Other Lipid Mediators. 172: 106836. PMID 38599513 DOI: 10.1016/j.prostaglandins.2024.106836 |
0.404 |
|
| 2024 |
Kang SK, Hawkins NA, Thompson CH, Baker EM, Echevarria-Cooper DM, Barse L, Thenstedt T, Dixon CJ, Speakes N, George AL, Kearney JA. Altered neurological and neurobehavioral phenotypes in a mouse model of the recurrent KCNB1-p.R306C voltage-sensor variant. Neurobiology of Disease. 106470. PMID 38485094 DOI: 10.1016/j.nbd.2024.106470 |
0.401 |
|
| 2023 |
Echevarria-Cooper DM, Kearney JA. Evaluating the interplay between estrous cyclicity and flurothyl-induced seizure susceptibility in mice. Micropublication Biology. 2023. PMID 38162411 DOI: 10.17912/micropub.biology.000850 |
0.353 |
|
| 2023 |
Echevarria-Cooper DM, Hawkins NA, Kearney JA. Strain-dependent effects on neurobehavioral and seizure phenotypes in mice. Biorxiv : the Preprint Server For Biology. PMID 37333275 DOI: 10.1101/2023.06.06.543929 |
0.323 |
|
| 2023 |
Echevarria-Cooper DM, Kearney JA. Evaluating the interplay between estrous cyclicity and induced seizure susceptibility in mice. Biorxiv : the Preprint Server For Biology. PMID 37163100 DOI: 10.1101/2023.04.27.538584 |
0.382 |
|
| 2023 |
Kang SK, Hawkins NA, Echevarria-Cooper DM, Baker EM, Dixon CJ, Speakes N, Kearney JA. Altered neurological and neurobehavioral phenotypes in a mouse model of the recurrent -p.R306C voltage-sensor variant. Biorxiv : the Preprint Server For Biology. PMID 37034689 DOI: 10.1101/2023.03.29.534736 |
0.4 |
|
| 2023 |
Forrest MP, Dos Santos M, Piguel NH, Wang YZ, Hawkins NA, Bagchi VA, Dionisio LE, Yoon S, Simkin D, Martin-de-Saavedra MD, Gao R, Horan KE, George AL, LeDoux MS, Kearney JA, et al. Rescue of neuropsychiatric phenotypes in a mouse model of 16p11.2 duplication syndrome by genetic correction of an epilepsy network hub. Nature Communications. 14: 825. PMID 36808153 DOI: 10.1038/s41467-023-36087-x |
0.339 |
|
| 2023 |
Anderson LL, Bahceci DA, Hawkins NA, Everett-Morgan D, Banister SD, Kearney JA, Arnold JC. Heterozygous deletion of Gpr55 does not affect a hyperthermia-induced seizure, spontaneous seizures or survival in the Scn1a+/- mouse model of Dravet syndrome. Plos One. 18: e0280842. PMID 36701411 DOI: 10.1371/journal.pone.0280842 |
0.421 |
|
| 2022 |
Kearney JA, Copeland-Hardin LD, Duarte S, Zachwieja NA, Eckart-Frank IK, Hawkins NA. Fine mapping and candidate gene analysis of a dravet syndrome modifier locus on mouse chromosome 11. Mammalian Genome : Official Journal of the International Mammalian Genome Society. PMID 35606653 DOI: 10.1007/s00335-022-09955-y |
0.369 |
|
| 2022 |
Tanenhaus A, Stowe T, Young A, McLaughlin J, Aeran R, Lin W, Li J, Hosur R, Chen M, Leedy J, Chou T, Pillay S, Vila MC, Kearney JA, Moorhead M, et al. Cell-selective AAV-mediated Gene Regulation Therapy Rescues Mortality and Seizure Phenotypes in a Dravet Syndrome Mouse Model and is Well Tolerated in Non-human Primates. Human Gene Therapy. PMID 35435735 DOI: 10.1089/hum.2022.037 |
0.373 |
|
| 2022 |
Echevarria-Cooper DM, Hawkins NA, Misra SN, Huffman AM, Thaxton T, Thompson CH, Ben-Shalom R, Nelson AD, Lipkin AM, George AL, Bender KJ, Kearney JA. Cellular and behavioral effects of altered NaV1.2 sodium channel ion permeability in Scn2aK1422E mice. Human Molecular Genetics. PMID 35417922 DOI: 10.1093/hmg/ddac087 |
0.399 |
|
| 2022 |
Gertler TS, Cherian S, DeKeyser JM, Kearney JA, George AL. K1.1 gain-of-function preferentially dampens excitability of murine parvalbumin-positive interneurons. Neurobiology of Disease. 168: 105713. PMID 35346832 DOI: 10.1016/j.nbd.2022.105713 |
0.438 |
|
| 2021 |
Anderson LL, Doohan PT, Hawkins NA, Bahceci D, Thakur GA, Kearney JA, Arnold JC. The endocannabinoid system impacts seizures in a mouse model of Dravet syndrome. Neuropharmacology. 108897. PMID 34822817 DOI: 10.1016/j.neuropharm.2021.108897 |
0.432 |
|
| 2021 |
Hawkins NA, Jurado M, Thaxton TT, Duarte SE, Barse L, Tatsukawa T, Yamakawa K, Nishi T, Kondo S, Miyamoto M, Abrahams BS, During MJ, Kearney JA. Soticlestat, a novel cholesterol 24-hydroxylase inhibitor, reduces seizures and premature death in Dravet syndrome mice. Epilepsia. PMID 34510432 DOI: 10.1111/epi.17062 |
0.394 |
|
| 2021 |
Anderson LL, Heblinski M, Absalom NL, Hawkins NA, Bowen M, Benson MJ, Zhang F, Bahceci D, Doohan PT, Chebib M, McGregor IS, Kearney JA, Arnold JC. Cannabigerolic acid, a major biosynthetic precursor molecule in cannabis, exhibits divergent effects on seizures in mouse models of epilepsy. British Journal of Pharmacology. PMID 34384142 DOI: 10.1111/bph.15661 |
0.354 |
|
| 2021 |
Hawkins NA, Nomura T, Duarte S, Barse L, Williams RW, Homanics GE, Mulligan MK, Contractor A, Kearney JA. Gabra2 is a genetic modifier of Dravet syndrome in mice. Mammalian Genome : Official Journal of the International Mammalian Genome Society. PMID 34086081 DOI: 10.1007/s00335-021-09877-1 |
0.353 |
|
| 2021 |
Satpute Janve V, Anderson LL, Bahceci D, Hawkins NA, Kearney JA, Arnold JC. The Heat Sensing Trpv1 Receptor Is Not a Viable Anticonvulsant Drug Target in the Mouse Model of Dravet Syndrome. Frontiers in Pharmacology. 12: 675128. PMID 34079465 DOI: 10.3389/fphar.2021.675128 |
0.424 |
|
| 2020 |
Hawkins NA, Misra SN, Jurado M, Kang SK, Vierra NC, Nguyen K, Wren L, George AL, Trimmer JS, Kearney JA. Epilepsy and neurobehavioral abnormalities in mice with a dominant-negative KCNB1 pathogenic variant. Neurobiology of Disease. 147: 105141. PMID 33132203 DOI: 10.1016/j.nbd.2020.105141 |
0.359 |
|
| 2020 |
Zaman T, Helbig KL, Clatot J, Thompson CH, Kang SK, Stouffs K, Jansen AE, Verstraete L, Jacquinet A, Parrini E, Guerrini R, Fujiwara Y, Miyatake S, Ben-Zeev B, Bassan H, ... ... Kearney JA, et al. SCN3A-related neurodevelopmental disorder: A spectrum of epilepsy and brain malformation. Annals of Neurology. PMID 32515017 DOI: 10.1002/Ana.25809 |
0.456 |
|
| 2020 |
Calhoun JD, Huffman AM, Bellinski I, Kinsley L, Bachman E, Gerard E, Kearney JA, Carvill GL. CACNA1H variants are not a cause of monogenic epilepsy. Human Mutation. PMID 32227660 DOI: 10.1002/Humu.24017 |
0.496 |
|
| 2020 |
Jones JE, Asato MR, Brown MG, Doss JL, Felton EA, Kearney JA, Talos D, Dacks PA, Whittemore V, Poduri A. Epilepsy Benchmarks Area IV: Limit or Prevent Adverse Consequence of Seizures and Their Treatment Across the Life Span. Epilepsy Currents. 1535759719895277. PMID 31973592 DOI: 10.1177/1535759719895277 |
0.354 |
|
| 2019 |
Kang SK, Vanoye CG, Misra SN, Echevarria DM, Calhoun JD, O'Connor JB, Fabre KL, McKnight D, Demmer L, Goldenberg P, Grote LE, Thiffault I, Saunders C, Strauss KA, Torkamani A, ... ... Kearney JA, et al. Spectrum of K 2.1 Dysfunction in KCNB1-Associated Neurodevelopmental Disorders. Annals of Neurology. PMID 31600826 DOI: 10.1002/Ana.25607 |
0.363 |
|
| 2019 |
Nomura T, Hawkins NA, Kearney JA, George AL, Contractor A. Potentiating α subunit containing perisomatic GABA receptors protects against seizures in a mouse model of Dravet syndrome. The Journal of Physiology. PMID 31045243 DOI: 10.1113/Jp277651 |
0.417 |
|
| 2019 |
Kang SK, Hawkins NA, Kearney JA. C57BL/6J and C57BL/6N substrains differentially influence phenotype severity in the mouse model of Dravet syndrome. Epilepsia Open. 4: 164-169. PMID 30868126 DOI: 10.1002/epi4.12287 |
0.351 |
|
| 2018 |
Hawkins NA, Calhoun JD, Huffman AM, Kearney JA. Gene expression profiling in a mouse model of Dravet syndrome. Experimental Neurology. PMID 30347190 DOI: 10.1016/J.Expneurol.2018.10.010 |
0.429 |
|
| 2018 |
Favero M, Sotuyo NP, Lopez E, Kearney JA, Goldberg EM. A transient developmental window of fast-spiking interneuron dysfunction in a mouse model of Dravet syndrome. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 30104343 DOI: 10.1523/Jneurosci.0193-18.2018 |
0.534 |
|
| 2018 |
Kearney JA. Expanding the Zebrafish Toolkit for Epilepsy Research Epilepsy Currents. 18: 56-58. PMID 29844769 DOI: 10.5698/1535-7597.18.1.56 |
0.384 |
|
| 2018 |
Baker EM, Thompson CH, Hawkins NA, Wagnon JL, Wengert ER, Patel MK, George AL, Meisler MH, Kearney JA. The novel sodium channel modulator GS-458967 (GS967) is an effective treatment in a mouse model of SCN8A encephalopathy. Epilepsia. PMID 29782051 DOI: 10.1111/Epi.14196 |
0.515 |
|
| 2018 |
Misra SN, Kearney JA. Alphabet Soup: Recurrent De Novo Mutations in Novel Genes Causing Developmental and Epileptic Encephalopathies. Epilepsy Currents. 18: 125-127. PMID 29671845 DOI: 10.5698/1535-7597.18.2.125 |
0.404 |
|
| 2018 |
Xu D, Robinson AP, Ishii T, Duncan DS, Alden TD, Goings GE, Ifergan I, Podojil JR, Penaloza-MacMaster P, Kearney JA, Swanson GT, Miller SD, Koh S. Peripherally derived T regulatory and γδ T cells have opposing roles in the pathogenesis of intractable pediatric epilepsy. The Journal of Experimental Medicine. PMID 29487082 DOI: 10.1084/Jem.20171285 |
0.359 |
|
| 2017 |
Calhoun JD, Vanoye CG, Kok F, George AL, Kearney JA. Characterization of a KCNB1 variant associated with autism, intellectual disability, and epilepsy. Neurology. Genetics. 3: e198. PMID 29264390 DOI: 10.1212/Nxg.0000000000000198 |
0.431 |
|
| 2017 |
Kearney JA. A Look Behind the Curtain: Epilepsy Microarray Consortium Epilepsy Currents. 17: 374-376. PMID 29217985 DOI: 10.5698/1535-7597.17.6.374 |
0.452 |
|
| 2017 |
Hawkins NA, Lewis M, Hammond RS, Doherty JJ, Kearney JA. The synthetic neuroactive steroid SGE-516 reduces seizure burden and improves survival in a Dravet syndrome mouse model. Scientific Reports. 7: 15327. PMID 29127345 DOI: 10.1038/S41598-017-15609-W |
0.487 |
|
| 2017 |
Calhoun JD, Hawkins NA, Zachwieja NJ, Kearney JA. Cacna1g is a genetic modifier of epilepsy in a mouse model of Dravet syndrome. Epilepsia. PMID 28556246 DOI: 10.1111/Epi.13811 |
0.572 |
|
| 2017 |
Hawkins NA, Anderson LL, Gertler TS, Laux L, George AL, Kearney JA. Screening of conventional anticonvulsants in a genetic mouse model of epilepsy. Annals of Clinical and Translational Neurology. 4: 326-339. PMID 28491900 DOI: 10.1002/Acn3.413 |
0.516 |
|
| 2017 |
Anderson LL, Hawkins NA, Thompson CH, Kearney JA, George AL. Unexpected Efficacy of a Novel Sodium Channel Modulator in Dravet Syndrome. Scientific Reports. 7: 1682. PMID 28490751 DOI: 10.1038/S41598-017-01851-9 |
0.502 |
|
| 2017 |
Kearney JA. Sodium Channel β Subunits in Epilepsy: Location, Location, Location. Epilepsy Currents. 17: 52-53. PMID 28331474 DOI: 10.5698/1535-7511-17.1.52 |
0.396 |
|
| 2017 |
Lamar T, Vanoye CG, Calhoun J, Wong JC, Dutton SB, Jorge BS, Velinov M, Escayg A, Kearney JA. SCN3A deficiency associated with increased seizure susceptibility. Neurobiology of Disease. PMID 28235671 DOI: 10.1016/J.Nbd.2017.02.006 |
0.549 |
|
| 2017 |
Thompson CH, Hawkins NA, Kearney JA, George AL. CaMKII modulates sodium current in neurons from epileptic Scn2a mutant mice. Proceedings of the National Academy of Sciences of the United States of America. PMID 28137877 DOI: 10.1073/Pnas.1615774114 |
0.445 |
|
| 2016 |
Hawkins NA, Zachwieja NJ, Miller AR, Anderson LL, Kearney JA. Fine Mapping of a Dravet Syndrome Modifier Locus on Mouse Chromosome 5 and Candidate Gene Analysis by RNA-Seq. Plos Genetics. 12: e1006398. PMID 27768696 DOI: 10.1371/Journal.Pgen.1006398 |
0.553 |
|
| 2016 |
Calhoun JD, Hawkins NA, Zachwieja NJ, Kearney JA. Cacna1g is a genetic modifier of epilepsy caused by mutation of voltage-gated sodium channel Scn2a. Epilepsia. PMID 27112236 DOI: 10.1111/Epi.13390 |
0.57 |
|
| 2016 |
Kearney JA. Locus Heterogeneity in Epilepsy of Infancy with Migrating Focal Seizures. Epilepsy Currents. 16: 43-45. PMID 26900380 DOI: 10.5698/1535-7597-16.1.43 |
0.466 |
|
| 2016 |
Hawkins NA, Kearney JA. Hlf is a genetic modifier of epilepsy caused by voltage-gated sodium channel mutations. Epilepsy Research. 119: 20-3. PMID 26656780 DOI: 10.1016/J.Eplepsyres.2015.11.016 |
0.538 |
|
| 2015 |
Kearney JA. KCNA2-Related Epileptic Encephalopathy Pediatric Neurology Briefs. 29: 27-27. PMID 26933568 DOI: 10.15844/Pedneurbriefs-29-4-2 |
0.395 |
|
| 2015 |
Kearney JA. Synaptopathies Heat Up: Mutations in STX1B in Fever-Associated Epilepsies. Epilepsy Currents / American Epilepsy Society. 15: 138-9. PMID 26316853 DOI: 10.5698/1535-7597-15.3.138 |
0.412 |
|
| 2015 |
Kearney JA. TALE of an SCN8A-Associated Epileptic Encephalopathy Mouse Model. Epilepsy Currents / American Epilepsy Society. 15: 83-4. PMID 26251648 DOI: 10.5698/1535-7597-15.2.83 |
0.36 |
|
| 2014 |
Torkamani A, Bersell K, Jorge BS, Bjork RL, Friedman JR, Bloss CS, Cohen J, Gupta S, Naidu S, Vanoye CG, George AL, Kearney JA. De novo KCNB1 mutations in epileptic encephalopathy. Annals of Neurology. 76: 529-40. PMID 25164438 DOI: 10.1002/Ana.24263 |
0.378 |
|
| 2014 |
Anderson LL, Thompson CH, Hawkins NA, Nath RD, Petersohn AA, Rajamani S, Bush WS, Frankel WN, Vanoye CG, Kearney JA, George AL. Antiepileptic activity of preferential inhibitors of persistent sodium current. Epilepsia. 55: 1274-83. PMID 24862204 DOI: 10.1111/Epi.12657 |
0.395 |
|
| 2014 |
Mistry AM, Thompson CH, Miller AR, Vanoye CG, George AL, Kearney JA. Strain- and age-dependent hippocampal neuron sodium currents correlate with epilepsy severity in Dravet syndrome mice. Neurobiology of Disease. 65: 1-11. PMID 24434335 DOI: 10.1016/J.Nbd.2014.01.006 |
0.37 |
|
| 2014 |
Vanoye CG, Gurnett CA, Holland KD, George AL, Kearney JA. Novel SCN3A variants associated with focal epilepsy in children. Neurobiology of Disease. 62: 313-22. PMID 24157691 DOI: 10.1016/J.Nbd.2013.10.015 |
0.522 |
|
| 2014 |
Miller AR, Hawkins NA, McCollom CE, Kearney JA. Mapping genetic modifiers of survival in a mouse model of Dravet syndrome. Genes, Brain, and Behavior. 13: 163-72. PMID 24152123 DOI: 10.1111/Gbb.12099 |
0.557 |
|
| 2014 |
Bersell KR, Jorge BS, Kearney JA, George AL. Epilepsy-Associated Point Mutation in the Pore Domain of Kv2.1 Biophysical Journal. 106. DOI: 10.1016/J.Bpj.2013.11.2438 |
0.494 |
|
| 2013 |
Kearney JA. Less is More: Reducing Tau Ameliorates Seizures in Epilepsy Models. Epilepsy Currents / American Epilepsy Society. 13: 184-5. PMID 24009485 DOI: 10.5698/1535-7597-13.4.184 |
0.459 |
|
| 2013 |
Kearney J. Voltage-gated ion channel accessory subunits: sodium, potassium, or both? Epilepsy Currents. 13: 30-31. PMID 23447736 DOI: 10.5698/1535-7511-13.1.30 |
0.329 |
|
| 2013 |
Kearney J. A mutation hot-spot for benign infantile epilepsy. Epilepsy Currents. 13: 20-21. PMID 23447732 DOI: 10.5698/1535-7511-13.1.20 |
0.459 |
|
| 2012 |
Kearney JA. Advances in epilepsy genetics and genomics. Epilepsy Currents / American Epilepsy Society. 12: 143-6. PMID 22936886 DOI: 10.5698/1535-7511-12.4.143 |
0.413 |
|
| 2012 |
Hawkins NA, Kearney JA. Confirmation of an epilepsy modifier locus on mouse chromosome 11 and candidate gene analysis by RNA-Seq. Genes, Brain, and Behavior. 11: 452-60. PMID 22471526 DOI: 10.1111/J.1601-183X.2012.00790.X |
0.556 |
|
| 2011 |
Jorge BS, Campbell CM, Miller AR, Rutter ED, Gurnett CA, Vanoye CG, George AL, Kearney JA. Voltage-gated potassium channel KCNV2 (Kv8.2) contributes to epilepsy susceptibility. Proceedings of the National Academy of Sciences of the United States of America. 108: 5443-8. PMID 21402906 DOI: 10.1073/Pnas.1017539108 |
0.572 |
|
| 2011 |
Hawkins NA, Martin MS, Frankel WN, Kearney JA, Escayg A. Neuronal voltage-gated ion channels are genetic modifiers of generalized epilepsy with febrile seizures plus. Neurobiology of Disease. 41: 655-60. PMID 21156207 DOI: 10.1016/J.Nbd.2010.11.016 |
0.575 |
|
| 2010 |
Wang DW, Mistry AM, Kahlig KM, Kearney JA, Xiang J, George AL. Propranolol blocks cardiac and neuronal voltage-gated sodium channels. Frontiers in Pharmacology. 1: 144. PMID 21833183 DOI: 10.3389/Fphar.2010.00144 |
0.33 |
|
| 2009 |
Bergren SK, Rutter ED, Kearney JA. Fine mapping of an epilepsy modifier gene on mouse Chromosome 19. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 20: 359-66. PMID 19513789 DOI: 10.1007/S00335-009-9193-6 |
0.553 |
|
| 2008 |
Holland KD, Kearney JA, Glauser TA, Buck G, Keddache M, Blankston JR, Glaaser IW, Kass RS, Meisler MH. Mutation of sodium channel SCN3A in a patient with cryptogenic pediatric partial epilepsy. Neuroscience Letters. 433: 65-70. PMID 18242854 DOI: 10.1016/J.Neulet.2007.12.064 |
0.529 |
|
| 2006 |
Levin SI, Khaliq ZM, Aman TK, Grieco TM, Kearney JA, Raman IM, Meisler MH. Impaired motor function in mice with cell-specific knockout of sodium channel Scn8a (NaV1.6) in cerebellar purkinje neurons and granule cells. Journal of Neurophysiology. 96: 785-93. PMID 16687615 DOI: 10.1152/Jn.01193.2005 |
0.367 |
|
| 2006 |
Kearney JA, Yang Y, Beyer B, Bergren SK, Claes L, Dejonghe P, Frankel WN. Severe epilepsy resulting from genetic interaction between Scn2a and Kcnq2. Human Molecular Genetics. 15: 1043-8. PMID 16464983 DOI: 10.1093/Hmg/Ddl019 |
0.586 |
|
| 2006 |
Kearney JA, Wiste AK, Stephani U, Trudeau MM, Siegel A, RamachandranNair R, Elterman RD, Muhle H, Reinsdorf J, Shields WD, Meisler MH, Escayg A. Recurrent de novo mutations of SCN1A in severe myoclonic epilepsy of infancy. Pediatric Neurology. 34: 116-20. PMID 16458823 DOI: 10.1016/J.Pediatrneurol.2005.07.009 |
0.532 |
|
| 2005 |
Turnbull J, Lohi H, Kearney JA, Rouleau GA, Delgado-Escueta AV, Meisler MH, Cossette P, Minassian BA. Sacred disease secrets revealed: the genetics of human epilepsy. Human Molecular Genetics. 14: 2491-2500. PMID 16278970 |
0.487 |
|
| 2005 |
Bergren SK, Chen S, Galecki A, Kearney JA. Genetic modifiers affecting severity of epilepsy caused by mutation of sodium channel Scn2a. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 16: 683-90. PMID 16245025 DOI: 10.1007/S00335-005-0049-4 |
0.577 |
|
| 2005 |
Meisler MH, Kearney JA. Sodium channel mutations in epilepsy and other neurological disorders. The Journal of Clinical Investigation. 115: 2010-7. PMID 16075041 DOI: 10.1172/Jci25466 |
0.503 |
|
| 2005 |
Turnbull J, Lohi H, Kearney JA, Rouleau GA, Delgado-Escueta AV, Meisler MH, Cossette P, Minassian BA. Sacred disease secrets revealed: the genetics of human epilepsy. Human Molecular Genetics. 14: 2491-500. PMID 16049035 DOI: 10.1093/Hmg/Ddi250 |
0.559 |
|
| 2004 |
Spampanato J, Kearney JA, de Haan G, McEwen DP, Escayg A, Aradi I, MacDonald BT, Levin SI, Soltesz I, Benna P, Montalenti E, Isom LL, Goldin AL, Meisler MH. A novel epilepsy mutation in the sodium channel SCN1A identifies a cytoplasmic domain for beta subunit interaction. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 10022-34. PMID 15525788 DOI: 10.1523/Jneurosci.2034-04.2004 |
0.443 |
|
| 2003 |
Weiss LA, Escayg A, Kearney JA, Trudeau M, MacDonald BT, Mori M, Reichert J, Buxbaum JD, Meisler MH. Sodium channels SCN1A, SCN2A and SCN3A in familial autism. Molecular Psychiatry. 8: 186-94. PMID 12610651 DOI: 10.1038/Sj.Mp.4001241 |
0.451 |
|
| 2002 |
Kearney JA, Buchner DA, De Haan G, Adamska M, Levin SI, Furay AR, Albin RL, Jones JM, Montal M, Stevens MJ, Sprunger LK, Meisler MH. Molecular and pathological effects of a modifier gene on deficiency of the sodium channel Scn8a (Na(v)1.6). Human Molecular Genetics. 11: 2765-75. PMID 12374766 DOI: 10.1093/Hmg/11.22.2765 |
0.405 |
|
| 2002 |
Meisler MH, Kearney JA, Sprunger LK, MacDonald BT, Buchner DA, Escayg A. Mutations of voltage-gated sodium channels in movement disorders and epilepsy. Novartis Foundation Symposium. 241: 72-81; discussion 82. PMID 11771652 DOI: 10.1002/0470846682.Ch6 |
0.479 |
|
| 2001 |
Meisler MH, Kearney J, Ottman R, Escayg A. Identification of epilepsy genes in human and mouse. Annual Review of Genetics. 35: 567-88. PMID 11700294 DOI: 10.1146/Annurev.Genet.35.102401.091142 |
0.556 |
|
| 2001 |
Meisler MH, Kearney J, Escayg A, MacDonald BT, Sprunger LK. Sodium channels and neurological disease: insights from Scn8a mutations in the mouse. The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry. 7: 136-45. PMID 11496924 DOI: 10.1177/107385840100700208 |
0.445 |
|
| 2001 |
Kearney JA, Plummer NW, Smith MR, Kapur J, Cummins TR, Waxman SG, Goldin AL, Meisler MH. A gain-of-function mutation in the sodium channel gene Scn2a results in seizures and behavioral abnormalities. Neuroscience. 102: 307-17. PMID 11166117 DOI: 10.1016/S0306-4522(00)00479-6 |
0.518 |
|
| 1998 |
Escayg A, Jones JM, Kearney JA, Hitchcock PF, Meisler MH. Calcium channel beta 4 (CACNB4): human ortholog of the mouse epilepsy gene lethargic. Genomics. 50: 14-22. PMID 9628818 DOI: 10.1006/Geno.1998.5311 |
0.359 |
|
| Show low-probability matches. |